Treatment with targeted vesicular stomatitis virus generates therapeutic multifunctional anti-tumor memory CD4 T cells.
about
Yellow fever vaccine 17D administered to healthy women aged between 40 and 54 years halves breast cancer risk: an observational study.Variability in CRP, regulatory T cells and effector T cells over time in gynaecological cancer patients: a study of potential oscillatory behaviour and correlationsViral infection of implanted meningeal tumors induces antitumor memory T-cells to travel to the brain and eliminate established tumors.Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy.Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a "Hammer" and "Anvil".
P2860
Treatment with targeted vesicular stomatitis virus generates therapeutic multifunctional anti-tumor memory CD4 T cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Treatment with targeted vesicu ...... anti-tumor memory CD4 T cells.
@ast
Treatment with targeted vesicu ...... anti-tumor memory CD4 T cells.
@en
type
label
Treatment with targeted vesicu ...... anti-tumor memory CD4 T cells.
@ast
Treatment with targeted vesicu ...... anti-tumor memory CD4 T cells.
@en
prefLabel
Treatment with targeted vesicu ...... anti-tumor memory CD4 T cells.
@ast
Treatment with targeted vesicu ...... anti-tumor memory CD4 T cells.
@en
P2093
P2860
P356
P1433
P1476
Treatment with targeted vesicu ...... anti-tumor memory CD4 T cells.
@en
P2093
J A Griffin
P Whitaker-Dowling
P2860
P2888
P304
P356
10.1038/CGT.2011.90
P50
P577
2012-01-13T00:00:00Z